|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The Journal of Immunology, Vol 147, Issue 9 3139-3144, Copyright © 1991 by American Association of Immunologists
ARTICLES |
BJ Mady, DV Erbe, I Kurane, MW Fanger and FA Ennis
Department of Medicine, University of Massachusetts, Medical Center, Worcester 01655.
It is known that antibodies to dengue viruses at subneutralizing concentrations enhance dengue virus infection of Fc gamma R+ cells. This phenomenon called antibody-dependent enhancement (ADE) occurs when virus-antibody complexes bind to the Fc gamma R via the Fc portion of the Ig. It has been hypothesized that ADE may be responsible for the pathogenesis of the severe manifestations of dengue virus infection including dengue hemorrhagic fever/dengue shock syndrome. To further analyze the mechanisms of ADE, we prepared bispecific antibodies by chemically cross-linking antidengue virus antibodies to antibodies specific for Fc gamma RI or Fc gamma RII and the non-Fc R molecules beta2 microglobulin, CD15 or CD33 and examined whether these bispecific antibodies could enhance infection. Bispecific antibodies targeting dengue virus to Fc gamma RI or Fc gamma RII enhanced dengue virus infection, consistent with previous reports using conventional antibodies. Furthermore, bispecific antibodies targeting dengue virus to beta2 microglobulin, CD15 or CD33 also enhanced dengue virus infection. Bispecific antibody mediated ADE was inhibited by pretreating the cells with the appropriate blocking mAb. These results indicate that cell surface molecules other than Fc gamma R can mediate ADE and suggest that the Fc gamma R does not provide a unique signal necessary for enhanced infection. We hypothesize that directing dengue virus to the cell surface by a bispecific antibody facilitates the interaction between dengue virus and its receptor, thereby increasing its infectivity.
This article has been cited by other articles:
![]() |
Y.-C. Chen, H.-N. Huang, C.-T. Lin, Y.-F. Chen, C.-C. King, and H.-C. Wu Generation and Characterization of Monoclonal Antibodies against Dengue Virus Type 1 for Epitope Mapping and Serological Detection by Epitope-Based Peptide Antigens Clin. Vaccine Immunol., April 1, 2007; 14(4): 404 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. S. I. Rodrigo, X. Jin, S. D. Blackley, R. C. Rose, and J. J. Schlesinger Differential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human Fc{gamma}RIA (CD64) or Fc{gamma}RIIA (CD32). J. Virol., October 1, 2006; 80(20): 10128 - 10138. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Adams, E. C. Holmes, C. Zhang, M. P. Mammen Jr, S. Nimmannitya, S. Kalayanarooj, and M. Boots Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok PNAS, September 19, 2006; 103(38): 14234 - 14239. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-J. Huang, Y.-C. Yang, Y.-S. Lin, J.-H. Huang, H.-S. Liu, T.-M. Yeh, S.-H. Chen, C.-C. Liu, and H.-Y. Lei The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J. Immunol., March 1, 2006; 176(5): 2825 - 2832. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-F. Lin, S.-C. Chiu, Y.-L. Hsiao, S.-W. Wan, H.-Y. Lei, A.-L. Shiau, H.-S. Liu, T.-M. Yeh, S.-H. Chen, C.-C. Liu, et al. Expression of Cytokine, Chemokine, and Adhesion Molecules during Endothelial Cell Activation Induced by Antibodies against Dengue Virus Nonstructural Protein 1 J. Immunol., January 1, 2005; 174(1): 395 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cologna and R. Rico-Hesse American Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic Cells J. Virol., April 1, 2003; 77(7): 3929 - 3938. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-F. Lin, H.-Y. Lei, A.-L. Shiau, H.-S. Liu, T.-M. Yeh, S.-H. Chen, C.-C. Liu, S.-C. Chiu, and Y.-S. Lin Endothelial Cell Apoptosis Induced by Antibodies Against Dengue Virus Nonstructural Protein 1 Via Production of Nitric Oxide J. Immunol., July 15, 2002; 169(2): 657 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. d. J. Martinez-Barragan and R. M. del Angel Identification of a Putative Coreceptor on Vero Cells That Participates in Dengue 4 Virus Infection J. Virol., September 1, 2001; 75(17): 7818 - 7827. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Diamond, D. Edgil, T. G. Roberts, B. Lu, and E. Harris Infection of Human Cells by Dengue Virus Is Modulated by Different Cell Types and Viral Strains J. Virol., September 1, 2000; 74(17): 7814 - 7823. [Abstract] [Full Text] |
||||
![]() |
J. M. Fox and M. E. Bloom Identification of a Cell Surface Protein from Crandell Feline Kidney Cells That Specifically Binds Aleutian Mink Disease Parvovirus J. Virol., May 1, 1999; 73(5): 3835 - 3842. [Abstract] [Full Text] |
||||
![]() |
N. Ferguson, R. Anderson, and S. Gupta The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens PNAS, January 19, 1999; 96(2): 790 - 794. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |